Personal tools

Coexpression cluster:C404: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
(Created page with "{{Coexpression_clusters |full_id=C404_Fibroblast_mesenchymal_Synoviocyte_Smooth_basal_mesodermal_Chondrocyte |id=C404 }}")
 
No edit summary
Line 2: Line 2:
|full_id=C404_Fibroblast_mesenchymal_Synoviocyte_Smooth_basal_mesodermal_Chondrocyte
|full_id=C404_Fibroblast_mesenchymal_Synoviocyte_Smooth_basal_mesodermal_Chondrocyte
|id=C404
|id=C404
|ontology_enrichment_celltype=CL:0000055!3.03e-19!180;CL:0000057!2.74e-16!75;CL:0000222!2.78e-11!119;CL:0000680!3.28e-09!57;CL:0000056!3.28e-09!57;CL:0000355!3.28e-09!57;CL:0000187!5.92e-08!54;CL:0002620!1.93e-07!23;CL:0000359!2.36e-07!32;CL:0000183!3.23e-07!59
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0004872!6.75e-16!84;UBERON:0000055!2.87e-13!69;UBERON:0000914!3.67e-13!83;UBERON:0002329!3.67e-13!83;UBERON:0003077!3.67e-13!83;UBERON:0003059!3.67e-13!83;UBERON:0007282!3.67e-13!83;UBERON:0009618!3.67e-13!83;UBERON:0007285!3.67e-13!83;UBERON:0000477!6.13e-13!286;UBERON:0000468!1.46e-12!659;UBERON:0002049!1.73e-12!79;UBERON:0007798!1.73e-12!79;UBERON:0004111!1.88e-12!241;UBERON:0001981!3.60e-12!60;UBERON:0007500!3.60e-12!60;UBERON:0004537!3.60e-12!60;UBERON:0006965!3.60e-12!60;UBERON:0004290!7.39e-12!70;UBERON:0000475!1.59e-11!365;UBERON:0000119!3.42e-11!312;UBERON:0000483!5.10e-11!309;UBERON:0002385!6.25e-11!63;UBERON:0001015!6.25e-11!63;UBERON:0000383!6.25e-11!63;UBERON:0001637!1.01e-10!42;UBERON:0003509!1.01e-10!42;UBERON:0004572!1.01e-10!42;UBERON:0000486!1.72e-10!82;UBERON:0001134!2.20e-10!61;UBERON:0002036!2.20e-10!61;UBERON:0003082!2.20e-10!61;UBERON:0000467!3.13e-10!625;UBERON:0000480!3.31e-10!626;UBERON:0000481!3.48e-10!347;UBERON:0004573!1.35e-09!33;UBERON:0004571!1.35e-09!33;UBERON:0001009!2.75e-09!113;UBERON:0004535!6.23e-09!110;UBERON:0000025!1.15e-08!194;UBERON:0007023!1.56e-08!115;UBERON:0003102!4.22e-08!95;UBERON:0003914!8.01e-08!118;UBERON:0000490!1.35e-07!138;UBERON:0005256!1.61e-07!143;UBERON:0000947!2.86e-07!21;UBERON:0010191!2.86e-07!21
}}
}}

Revision as of 14:43, 21 May 2012


Full id: C404_Fibroblast_mesenchymal_Synoviocyte_Smooth_basal_mesodermal_Chondrocyte



Phase1 CAGE Peaks

Hg19::chr3:100468772..100468781,-p@chr3:100468772..100468781
-
Hg19::chr3:100494130..100494141,-p@chr3:100494130..100494141
-
Hg19::chr3:100494155..100494167,-p@chr3:100494155..100494167
-
Hg19::chr3:100497204..100497224,-p5@ABI3BP
Hg19::chr3:100499042..100499055,-p@chr3:100499042..100499055
-
Hg19::chr3:100513811..100513820,-p@chr3:100513811..100513820
-
Hg19::chr3:100513821..100513835,-p@chr3:100513821..100513835
-
Hg19::chr3:100527043..100527076,-p8@ABI3BP
Hg19::chr3:100551141..100551152,-p14@ABI3BP
Hg19::chr3:100551992..100552008,-p@chr3:100551992..100552008
-
Hg19::chr3:100553556..100553602,-p@chr3:100553556..100553602
-
Hg19::chr3:100554469..100554494,-p@chr3:100554469..100554494
-
Hg19::chr3:100557118..100557130,-p@chr3:100557118..100557130
-
Hg19::chr3:100557278..100557294,-p@chr3:100557278..100557294
-
Hg19::chr3:100557300..100557309,-p@chr3:100557300..100557309
-
Hg19::chr3:100558953..100558982,-p6@ABI3BP
Hg19::chr3:100565249..100565269,-p7@ABI3BP
Hg19::chr3:100566492..100566523,-p3@ABI3BP
Hg19::chr3:100567644..100567686,+p@chr3:100567644..100567686
+
Hg19::chr3:100567665..100567691,-p@chr3:100567665..100567691
-
Hg19::chr3:100567697..100567718,-p@chr3:100567697..100567718
-
Hg19::chr3:100568922..100568933,-p@chr3:100568922..100568933
-
Hg19::chr3:100568942..100568975,-p@chr3:100568942..100568975
-
Hg19::chr3:100617652..100617669,-p@chr3:100617652..100617669
-
Hg19::chr3:100712253..100712274,-p1@ABI3BP
Hg19::chr3:100712292..100712338,-p2@ABI3BP


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


No GOStat results

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Uber Anatomy
Ontology termp-valuen
splanchnic layer of lateral plate mesoderm6.75e-1684
vessel2.87e-1369
somite3.67e-1383
paraxial mesoderm3.67e-1383
presomitic mesoderm3.67e-1383
presumptive segmental plate3.67e-1383
trunk paraxial mesoderm3.67e-1383
presumptive paraxial mesoderm3.67e-1383
anatomical cluster6.13e-13286
multi-cellular organism1.46e-12659
vasculature1.73e-1279
vascular system1.73e-1279
anatomical conduit1.88e-12241
blood vessel3.60e-1260
epithelial tube open at both ends3.60e-1260
blood vasculature3.60e-1260
vascular cord3.60e-1260
dermomyotome7.39e-1270
organism subdivision1.59e-11365
cell layer3.42e-11312
epithelium5.10e-11309
muscle tissue6.25e-1163
musculature6.25e-1163
musculature of body6.25e-1163
artery1.01e-1042
arterial blood vessel1.01e-1042
arterial system1.01e-1042
multilaminar epithelium1.72e-1082
skeletal muscle tissue2.20e-1061
striated muscle tissue2.20e-1061
myotome2.20e-1061
anatomical system3.13e-10625
anatomical group3.31e-10626
multi-tissue structure3.48e-10347
systemic artery1.35e-0933
systemic arterial system1.35e-0933
circulatory system2.75e-09113
cardiovascular system6.23e-09110
tube1.15e-08194
adult organism1.56e-08115
surface structure4.22e-0895
epithelial tube8.01e-08118
unilaminar epithelium1.35e-07138
trunk mesenchyme1.61e-07143
aorta2.86e-0721
aortic system2.86e-0721


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.